Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$329,905
New position
Shares Held
9,322
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#319
of 494 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Frec Markets, Inc. holds $8,586,783 across 18 Biotechnology names. ROIV ranks #10 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,778 | $1,379,915 | |
| 2 | INCY |
Incyte Corp
|
10,592 | $1,200,709 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
20,555 | $1,176,157 | |
| 4 | EXEL |
Exelixis, Inc.
|
14,365 | $781,599 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,246 | $776,930 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,618 | $487,066 | |
| 7 | RPRX |
Royalty Pharma plc
|
6,504 | $364,679 | |
| 8 | MRNA |
Moderna, Inc.
|
5,100 | $357,153 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $329,905 | 9,322 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||